BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30565310)

  • 1. Grading of renal cell carcinoma.
    Delahunt B; Eble JN; Egevad L; Samaratunga H
    Histopathology; 2019 Jan; 74(1):4-17. PubMed ID: 30565310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.
    Delahunt B; McKenney JK; Lohse CM; Leibovich BC; Thompson RH; Boorjian SA; Cheville JC
    Am J Surg Pathol; 2013 Mar; 37(3):311-22. PubMed ID: 23348209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gleason and Fuhrman no longer make the grade.
    Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
    Histopathology; 2016 Mar; 68(4):475-81. PubMed ID: 26266664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
    Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
    Delahunt B; Cheville JC; Martignoni G; Humphrey PA; Magi-Galluzzi C; McKenney J; Egevad L; Algaba F; Moch H; Grignon DJ; Montironi R; Srigley JR;
    Am J Surg Pathol; 2013 Oct; 37(10):1490-504. PubMed ID: 24025520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The WHO/ISUP grading system for renal carcinoma].
    Moch H
    Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
    Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].
    Kristiansen G; Delahunt B; Srigley JR; Lüders C; Lunkenheimer JM; Gevensleben H; Thiesler T; Montironi R; Egevad L
    Pathologe; 2015 May; 36(3):310-6. PubMed ID: 25398389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
    Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
    Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
    Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
    Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference.
    Delahunt B; Srigley JR; Montironi R; Egevad L
    Urology; 2014 May; 83(5):969-74. PubMed ID: 24661331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up.
    Przybycin CG; McKenney JK; Reynolds JP; Campbell S; Zhou M; Karafa MT; Magi-Galluzzi C
    Am J Surg Pathol; 2014 Sep; 38(9):1260-5. PubMed ID: 25127094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
    Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
    Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade.
    Browning L; Colling R; Verrill C
    Diagn Pathol; 2021 Aug; 16(1):75. PubMed ID: 34419085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma.
    Zhang BY; Cheville JC; Thompson RH; Lohse CM; Boorjian SA; Leibovich BC; Costello BA
    Eur Urol; 2015 Jul; 68(1):5-7. PubMed ID: 25638439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in Grading of Renal Cell Carcinomas Beyond Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma.
    Paner GP; Chumbalkar V; Montironi R; Moch H; Amin MB
    Adv Anat Pathol; 2022 May; 29(3):117-130. PubMed ID: 35275846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
    Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
    Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
    Moch H; Cubilla AL; Humphrey PA; Reuter VE; Ulbright TM
    Eur Urol; 2016 Jul; 70(1):93-105. PubMed ID: 26935559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
    Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.